Short Interest in CellaVision AB (publ) (OTCMKTS:CLVSF) Drops By 13.3%

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 1,300 shares, a decrease of 13.3% from the March 31st total of 1,500 shares. Based on an average trading volume of 200 shares, the short-interest ratio is currently 6.5 days.

CellaVision AB (publ) Price Performance

CLVSF stock remained flat at $20.24 during mid-day trading on Tuesday. CellaVision AB has a one year low of $20.24 and a one year high of $23.75. The business’s fifty day moving average is $21.12 and its 200 day moving average is $18.27.

About CellaVision AB (publ)

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.